Emond, Bruno <br/><br/>
Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans.  [electronic resource] 

 -  Current medical research and opinion  03 2019 
 - 407-416 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1080/03007995.2018.1560220  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antipsychotic Agents--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Paliperidone Palmitate--administration & dosage<br/>Retrospective Studies<br/>Schizophrenia--drug therapy